Cardiol Therapeutics Inc (CRDL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 57 | 57 | 56 | 50 | 40 |
| Accounts receivable | -106 | 917 | -165 | -338 | -138 |
| Other Working Capital | 705 | 1,308 | -343 | -1,139 | 790 |
| Other Operating Activity | -3,639 | -3,467 | -1,978 | -1,631 | -2,799 |
| Operating Cash Flow | $-2,983 | $-1,185 | $-2,429 | $-3,058 | $-2,107 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7 | -2 | -18 | -78 | -236 |
| Investing Cash Flow | $-7 | $-2 | $-18 | $-78 | $-236 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -13 | -12 | -12 | -12 | N/A |
| Common Stock Issued | 0 | 17,250 | 0 | 0 | 0 |
| Other Financing Activity | 115 | -1,114 | 0 | 0 | -8 |
| Financing Cash Flow | $102 | $16,124 | $-12 | $-12 | $-8 |
| Beginning Cash Position | 19,434 | 4,497 | 6,956 | 10,104 | 12,455 |
| End Cash Position | 16,547 | 19,434 | 4,497 | 6,956 | 10,104 |
| Net Cash Flow | $-2,887 | $14,937 | $-2,459 | $-3,148 | $-2,351 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,983 | -1,185 | -2,429 | -3,058 | -2,107 |
| Capital Expenditure | -7 | -2 | -18 | -78 | -236 |
| Free Cash Flow | -2,990 | -1,187 | -2,447 | -3,136 | -2,343 |